Literature DB >> 12209957

Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.

Isabelle Guilleret1, Pu Yan, Fabienne Grange, Richard Braunschweig, Fred T Bosman, Jean Benhattar.   

Abstract

DNA methylation is an epigenetic process involved in embryonic development, differentiation and aging. It is 1 of the mechanisms resulting in gene silencing in carcinogenesis, especially in tumor suppressor genes (e.g., p16, Rb). Telomerase, the DNA polymerase adding TTAGGG repeats to the chromosome end, is involved in the regulation of the replicative life span by maintaining telomere length. This enzyme is activated in germ and stem cells, repressed in normal somatic cells and reactivated in a large majority of tumor cells. The promoter region of the hTERT gene, encoding for the catalytic subunit of human telomerase, has been located in a CpG island and may therefore be regulated at least in part by DNA methylation. We analyzed the methylation status of 27 CpG sites within the hTERT promoter core region by methylation-sensitive single-strand conformation analysis (MS-SSCA) and direct sequencing using bisulfite-modified DNA in 56 human tumor cell lines, as well as tumor and normal tissues from different organs. A positive correlation was observed among hypermethylation of the hTERT promoter, hTERT mRNA expression and telomerase activity (p < 0.00001). Furthermore, this correlation was confirmed in normal tissues where hypermethylation of the hTERT promoter was found exclusively in hTERT-expressing telomerase-positive samples and was absent in telomerase-negative samples (p < 0.00002). Since tumor tissues contain also nonneoplastic stromal elements, we performed microdissection to allow confirmation that the hTERT promoter methylation truly occurred in tumor cells. Our results suggest that methylation may be involved in the regulation of hTERT gene expression. To our knowledge, this is the first gene in which methylation of its promoter sequence has been found to be positively correlated with gene expression. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209957     DOI: 10.1002/ijc.10593

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  93 in total

Review 1.  Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components.

Authors:  Y Li; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

2.  Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS.

Authors:  Xin Zhao; Xin Tian; Sachiko Kajigaya; Caroline R Cantilena; Stephen Strickland; Bipin N Savani; Sanjay Mohan; Xingmin Feng; Keyvan Keyvanfar; Neil Dunavin; Danielle M Townsley; Bogdan Dumitriu; Minoo Battiwalla; Katayoun Rezvani; Neal S Young; A John Barrett; Sawa Ito
Journal:  Br J Haematol       Date:  2016-07-19       Impact factor: 6.998

3.  A non-genetic, epigenetic-like mechanism of telomere length inheritance?

Authors:  Tim De Meyer; Katrien Vandepitte; Simon Denil; Marc L De Buyzere; Ernst R Rietzschel; Sofie Bekaert
Journal:  Eur J Hum Genet       Date:  2013-10-23       Impact factor: 4.246

4.  The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells.

Authors:  Nathan J Hansen; Rebecca C Wylie; Sharla M O Phipps; William K Love; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Int J Oncol       Date:  2007-03       Impact factor: 5.650

5.  Differential expression of epigenetic modulators during human embryonic stem cell differentiation.

Authors:  Sharla M O Phipps; William K Love; Troy E Mott; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Mol Biotechnol       Date:  2008-10-25       Impact factor: 2.695

6.  Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.

Authors:  Shigeo Ohba; Joydeep Mukherjee; Tor-Christian Johannessen; Andrew Mancini; Tracy T Chow; Matthew Wood; Lindsey Jones; Tali Mazor; Roxanne E Marshall; Pavithra Viswanath; Kyle M Walsh; Arie Perry; Robert J A Bell; Joanna J Phillips; Joseph F Costello; Sabrina M Ronen; Russell O Pieper
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

7.  DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.

Authors:  Donghyun D Lee; Ricardo Leão; Martin Komosa; Marco Gallo; Cindy H Zhang; Tatiana Lipman; Marc Remke; Abolfazl Heidari; Nuno Miguel Nunes; Joana D Apolónio; Aryeh J Price; Ramon Andrade De Mello; João S Dias; David Huntsman; Thomas Hermanns; Peter J Wild; Robert Vanner; Gelareh Zadeh; Jason Karamchandani; Sunit Das; Michael D Taylor; Cynthia E Hawkins; Jonathan D Wasserman; Arnaldo Figueiredo; Robert J Hamilton; Mark D Minden; Khalida Wani; Bill Diplas; Hai Yan; Kenneth Aldape; Mohammad R Akbari; Arnavaz Danesh; Trevor J Pugh; Peter B Dirks; Pedro Castelo-Branco; Uri Tabori
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

8.  hTERT methylation is necessary but not sufficient for telomerase activity in colorectal cells.

Authors:  Cristina Valls-Bautista; Stéphanie Bougel; Carme Piñol-Felis; Joan Viñas-Salas; Jean Benhattar
Journal:  Oncol Lett       Date:  2011-08-18       Impact factor: 2.967

9.  Repression of telomerase gene promoter requires human-specific genomic context and is mediated by multiple HDAC1-containing corepressor complexes.

Authors:  Yuanjun Zhao; Shuwen Wang; Fan Zhang; Mariano Russo; Steven B McMahon; Jiyue Zhu
Journal:  FASEB J       Date:  2016-12-09       Impact factor: 5.191

10.  Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.

Authors:  Syed M Meeran; Shweta N Patel; Trygve O Tollefsbol
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.